Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance) Journal Article


Authors: Brown, J. C.; Ma, C.; Shi, Q.; Zemla, T.; Couture, F.; Kuebler, P.; Kumar, P.; Tan, B.; Krishnamurthi, S.; Chang, V.; Goldberg, R. M.; Venook, A. P.; Blanke, C. D.; O’Reilly, E. M.; Shields, A. F.; Meyerhardt, J. A.
Article Title: Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)
Abstract: Background: One in three patients with stage III colon cancer will experience tumor recurrence. It is uncertain whether physical activity during and after postoperative chemotherapy for stage III colon cancer improves overall survival after tumor recurrence. Methods: A prospective cohort study nested within a randomized multicenter trial of patients initially diagnosed with stage III colon cancer who experienced tumor recurrence (N = 399) was conducted. Postoperative physical activity before tumor recurrence was measured. Physical activity energy expenditure was quantified via metabolic equivalent task hours per week (MET-h/week). The primary end point was overall survival after tumor recurrence. Multivariable flexible parametric survival models estimated relative and absolute effects with two-sided hypothesis tests. Results: Compared with patients expending <3.0 MET-h/week of physical activity (comparable to <1.0 h/week of brisk walking), patients with ≥18.0 MET-h/week of physical activity (comparable to 6 h/week of brisk walking) had a 33% relative improvement in overall survival time after tumor recurrence (hazard ratio, 0.67; 95% CI, 0.42–0.96). The overall survival rate at 3 years after tumor recurrence was 61.3% (95% CI, 51.8%–69.2%) with <3.0 MET-h/week of physical activity and 72.2% (95% CI, 63.1%–79.6%) with ≥18 MET-h/week of physical activity (risk difference, 10.9 percentage points; 95% CI, 1.2–20.8 percentage points). Conclusions: Higher postoperative physical activity is associated with improved overall survival after tumor recurrence in patients initially diagnosed with stage III colon cancer. These data may be relevant to patients who, despite optimal postoperative medical therapy, have a high risk of tumor recurrence. © 2023 American Cancer Society.
Keywords: adult; controlled study; disease-free survival; leukemia; major clinical study; overall survival; clinical trial; postoperative period; disease free survival; cancer staging; neoplasm staging; prospective study; prospective studies; neoplasm recurrence, local; randomized controlled trial; colonic neoplasms; cohort analysis; exercise; recurrence; pathology; multicenter study; tumor recurrence; colon cancer; colon tumor; recurrent disease; physical activity; cohort; energy expenditure; humans; human; male; female; article; colonic adenocarcinoma
Journal Title: Cancer
Volume: 129
Issue: 23
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2023-12-01
Start Page: 3724
End Page: 3734
Language: English
DOI: 10.1002/cncr.35007
PUBMED: 37651160
PROVIDER: scopus
PMCID: PMC10843498
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly